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Cancer of the cervix is the most common cancer among women India, constituting between
one-sixth to one-half of all female cancers with an age-adjusted incidence rate ranging from 19.4 to 43.5 per
100 000 in the repstries under the National Cancer Regwistry Programme (NCRP) (Annual Reports, NCRP,
ICMR). It has been estimated that 100 000 new cases of cancer of the cervix occur in India every year, and
70% or more of these are Stage m or higher at diais. However, the incidence of cancer of the cervix as
suggested in this report appears to be on the delin in Bangalore. Besies incidnce and clinical stage at
presentation knowledge of survival is essential to complte the pichtu of establshing baseline indicators to
monitor and evaluate cancer control programmes. Survival analysis was carried out in 2121 patients diagnosed
during 1982-89 in the population of Bangalore, India. The observed 5 year survival was 34.4% and the
relative survival 38.3%. Chnical stage at presentation was the single most important variable in predicting
survival. The 5 year observed survival for stage I disease was 63.3%, for stage 1144.0%, for stage IH 30.3%
and for stage IV 5.7%.
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Cancer of the cervix is the leading cancer in women and the
most common cancer among all sites in both sexes in the
developing world. The highest age-standardised/adjusted
incidence rates (ASRs) have been reported from Brazil
(Recife; 83.2 per 100000) and in Cali, Columbia (48.2 per
100000). Low incidence rates of cancer of the cervix have
been found in non-Jews in Israel, with an ASR of 3.0 per
100 000. The registries in India have recorded a high of 43.5
per 100000 in Madras and a low of 19.4 per 100000 in
Bombay (Tomatis et al., 1990; Whelan et al., 1990-, Annual
Reports 1989, 1990, NCRP, ICMR).
While incidence rates of cervix cancer are available from
quite a few centres in the developing world (Tomatis et al.,
1990), survival rates, including stage-speific survival rates,
especially on a population basis, are not. The inadequate
system of registration of death and incomplete or incorrect
certification of cause of death accompanied by poor patient
follow-up are the main reasons for the paucity of valid
mortality data and, therefore, lack of survival information on
cancer patients. This has been largely overcome in this
study.
Mariak and mwthods
Under the National Cancer Registry Programme of the
Indian Council of Medical Research a population-based
cancer registry (PBCR) was started from 1 January 1982 at
Kidwai Memorial Institute of Oncology, Bangalore. The
registry covers the area of Bangalore Urban Agglomeration
(which includes Bangalore city) with a total population of4.1
million (Census of India, 1991) and a male-female ratio of
1:0.9. The criterion for including cancer patients in the regis-
try is that the person should have resided in the registry area
for a minimum period of 1 year before the diagnosis of
cancer.
Kidwai Memorial Institute of Oncology (KIMIO) is a
comprehensive cancer centre and a referral hospital for
cancer patients with all modern facilities for diagnosis and
treatment. Consequently, it is the most important single
source of registration of cancer cases in the PBCR area and
accounted for 65.9% of cases of cancers of all sites and
87.3% of cancer cervix during the above period. Therefore,
this proportion of patients from the registry area get autom-
atically regisered with the registry and all details pertaining
to diagnosis and treatment become readily available. Trained
registry staff make periodic visits to other hospitals, nursing
homes and histopathology laboratories (numbering in all
about 30 major institutions and 200 smaller ones) in the
registry area of Bangalore Urban Agglomeration to abstract
details of cacer cases. Information so obtained in a core
proforma (the format of which is computerised) is entered on
a personal computer and duplicate and consistency checks
are carried out. The abstraction of the extent of disease and
stage is always carried out by a medical officer who is
familiar with clnical staging in oncology.
Records of deaths from all causes are scrutinised at 14
municipal corporation units, and information on cancer
deaths is abstracted. By means of personal data (name, age,
sex, etc.) these records are matched with the incident cases
obtained through hospitals and other sources. The matched
records constitute the matched deaths. The unmatched ones
are those considered as 'death certificates only' (DCO) and
by convention are added to the incilent cases of the relevant
year in calculating incidence rates, but are normally excluded
from survival analysis, since only the date of death of these
cases would be available and consequently their survival time
would be zero.
Taking into account the proportion (74.1% in males and
58.8% in females) of literates in the population (Nan-
dakumar et al., 1990), their health consciousness, the health
facilities available in the area and the cooperation extended
by these institutions, it is estimated that the coverage by the
registry would be over 90%.
Thus all patients (2423 cases) with cervical cancer (ICD:
180) diagnosed between 1 January 1982 and 31 December
1989 and registered in the PBCR of Bangalore constituted
the study group. Information that was available with the
registry included: date of diagnosis, area of residence and
duration of stay, age at diagnosis, most valid basis of diag-
nosis, educational and marital status, religious group and
clinical extent of disease before treatment. In order to obtain
a better assessment of the clinical extent at presentation, the
case records of all patients with cancer of the cervix were
once again reviewed for abstracting information on pre-
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27 January 1995treatment composite FIGO (International Federation of
Gynaecology and Obstetrics) stage at presentation. This was
available in 88.9% of patients. Since over 90% of patients in
each of the stages were classified as subgroup B at presenta-
tion, no attempt was made to subclassify further each of the
four stges under the FIGO cla tion into subgroups A
and B.
Age-specific rates and ASRs including trends over time
were calulated for all 2423 incidence cases that were
registered. Age-specific and age-standardised mortality rates
including trends over time were calculated for 1076 deaths
that occurred between 1 January 1982 and 31 December
1989. Standardisation of incidence and mortality rates was
achieved by the direct method usng the World Standard
Population (Boyle and Parkin, 1991). The age at diagnosis
and age at death were taken for caculating age-specific and
age-standardised incidence and mortality rates respectively.
The population of Bangalore Urban Agglomeration by 5
year age group and sex was esimated (as on 1 July of each
intercensal year) using the 1971 and 1981 quinquennial
population by sex and the total population of 1991 also by
sex (Census of India, 1971, 1981).
The esimated proportion of different religious groups for
the total population were available (Hindus, 76.5%; Mus-
lims, 15.2%; Chrisians, 7.2%; and others, 1.1%), therefore
crude incidence rates according to religion could be cal-
culated. However, the proportions of 5 year age distribution
of the populations by religious groups were not available and
therefore the age-standardised rates according to religious
groups could not be calculated.
Active follow-up through visits to the homes of patients
was performed by trained social investigators. The detailed
methodology ofactive follow-up is described elsewhere (Nan-
dakumar, 1993). Briefly, matched deaths, which constituted
7.6% (185 cases) of the total cases and 2.3% (55 cases) of
patients who were on attendance at KIMIO, were excluded
from active follow-up. Information from home visits and the
last hospital attended was obtained for the 45 cases for
whom death certificates were the only records that were
available as these did not match the records of other cases of
cervical cancer that were registered. House visits were
attempted for the remaining 2138 cases. January 1 1993, was
taken as the cut-off date for survival analysis, and the vital
status (whether alive or dead) on that date was determined
through these visits. Patients who had died during 1993 but
were alive on I January 1993 were considered alive for the
purpose of this analysis.
Active follow-up of2138 cases yielded information on vital
status in 1704 cases, partal follow-up information in 161
cases and no follow-up information in the remaining 273
cases. Of the 45 unmatched death certificate only (DCO)
cases that were 'followed back', the date of first diagnosis
was obtained in 16, and these were considered as matched
deaths, whereas the remaining 29 cases were considered as
DCO cases.
Thus, these 29 DCO cases, along with 273 cases for whom
no follow-up information subsequent to the date ofdiagnosis
was available, were excluded from survival analysis, leaving
2121 of 2423 (87.5%) cases for calculating survival. For the
161 patients in whom only partial follow-up was available it
was assumed that these patients were alive for exactly half
the period since they were last traced (Parkin and Hakulnen,
1991).
Observed survival was based on death from all causes. The
overall observed survival and that according to 10 year age
group, year of diagnosis, clinical stage (FIGO system of
staging), religious group and literary status were computed
using the Kaplan-Meier method of calculating survival
(Kaplan and Meier, 1958). The effects of age and mortality
from all causes of death (Corporation of the City of Ban-
galore, 1986, 1987) were removed by computing survival
relative to that expected in the total population of Bangalore
by age and sex using the life table method (Shryock and
Siegel, 1973). The factored variables that showed statstical
sign were introduced stepwise into a Cox regression
Cam c o _s en ingiwe, hua
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model (Cox, 1972) to remove the effects of one against the
other. Both survival and Cox's proportional hazard ratio
were calculated using the EGRET software package. Since
never married cases constituted less than 0.5% of the cases,
survival by marital status was not calculated.
Resdt
Incidence andmortality
The average annual crude and age-standardised incidence
rate (ASR) of cancer of the cervix in Bangalore for the
period 1982-89 was 18.6 and 28.8 per 100000 respectively.
Over the 8 year period there appeared to be a decrease in the
ASR, and this was statistically significant (P<0.02). The
average annual crude and age-adjusted death rate for the
period were 8.2 and 13.3 per 100000 respectively, giving a
mortality incidence ratio of 0.46.
The age-specific incidence and mortality rates are diagram-
matically shown in Figure 1. While the highest age-specific
incidnc rate of 106.2 per 100000 was seen in the 55-59
year age group, the highest age-specific mortality rate of 54.1
per 100000 was seen in the 65-69 year age group.
Crude incidence (CR) and mortality rates according to
religious groups were examined. The CR among Hindus
(21.2 per 100000) was almost three times higher than in
Muslims (CR = 7.7 per 100000). The corresponding CR
among Chnstians was 15.9 per 100000. There was no varia-
tion in the mortality incidence ratio between Hindus and
Muslims (0.44). In Christians this ratio was 0.51. Since age
distribution of the population according to religious groups
was not available, the age-adjusted rates could not be cal-
culated.
Incidence and mortality accoring to clinical stage Table I
gives the age-adjusted incidence and mortality rates accord-
ing to clinical stage as well as the mortality incidence ratio.
This ratio shows a rise with advancing stage of disease. The
table also gives the number and proportions of patients with
different stages of disease. If those patients with stage un-
known were excluded, only 3.4% of patients presented with
stage I disease and 68.6% of patients had stage III or IV
disease. From 1982 to 1989 a trend in the relative proportion
of each stage of disease was observed (Figure 2). During the
8 year period there was a statistically significant decline in
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the relative proportion of stage IV disease (P = 0.01) but no
significant change in the relative proportion of other stages.
Similarly, the trends in ASR according to clinical stage of
disease showed a statistically significant decline in stage III
and stage IV disease.
Survival analysis
The overall observed 5 year survival was 34.4% (Figure 3),
and when the 5 year probability of survival (0.898) in the
general population (among females of Bangalore) based on
death from all causes was taken into account, the relative
survival was 38.8%. Table II gives the patient characteristics
and observed 5 year survival proportion. The influence ofage
on survival was observed by calulating the hazard ratio for
both 5 and 10 year age groups. This was not statistically
significant. Five year observed survival was almost identical
in the different religious groups. The differences in survival
seen between illiterate and literate patients on univariate
analysis was not statistically significant when the clinical
stage of disease was also considered during multivariate
analysis (Table III). There was little difference in the
observed survival of patients during different years of diag-
nosis.
Tables II and III show that clinical stage was a strong
independent predictor ofsurvival. The corresponding survival
curves are shown in Figure 4.
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Discasion
India has one of the highest incidence rates of cancer of the
cervix, and the ASR of this cancer in Bangalore is second
only to that in Madras (Annual Reports. NCRP. ICMR;
Parkin et al., 1992). However, as observed in this study, there
appears to have been a statistically significant decline in the
incidence rate of cervical cancer in Bangalore. A dechne in
cervical cancer incidence has been reported in the western
world (Miller et al., 1992). One possible explanation for the
Table I Average age-adjusted incidence (IR) and mortality rates
(MR) per 100 000, mortality incidence ratio (MIR) and number
(No.) and proportion (%) according to clinical stage (FIGO
classification) of cancer of the cervix
FIGO stage IR MR MIR No. %
Stage I 0.85 0.25 0.29 74 3.1
Stage II 6.87 2.54 0.37 602 24.8
Stage III 16.62 8.04 0.48 1375 56.7
Stage IV 1.29 0.99 0.77 102 4.2
Stage unknown 3.15 1.45 0.46 270 11.1
All stages 28.79 13.27 0.46 2423 100.0
Table H Patient characteristics and observed 5 year survival
Patient No. of Five year
characteristics patients survival (%0
Age group (years)
<25 13 -
25-34 147 40.9
35-44 487 42.0
45-54 676 35.6
55-64 505 30.0
65-74 231 24.0
75+ 62 16.0
Religious group
Hindu 1841 34.4
Muslim 134 34.0
Christian 143 34.5
Others 3
Educational status
Illiterate 1361 33.8
Literate 675 37.2
Clinical stage
Stage I 69 63.3
Stage II 556 44.0
Stage III 1227 30.3
Stage IV 88 5.7
Unstaged 181 37.2
Tabe IH Independent predictors of observed survival using Cox
proportional hazards regression analysis
Hazard
Factor ratio 95% CI LRS P-value
Religious group 2.3 0.52
Hindu 1.0 -
Muslin 0.9 0.8-1.1
Christian 1.0 0.8- 1.2
Others 0.3
Educational status 4.1 0.043
Illiterate 1.0
Literate 0.9 0.8 1.0
Clinical extent 122.7 <0.001
Stage I 1.0 -
Stage II 1.9 1.3-2.7
Stage III 2.6 1.8-3.8
Stage IV 6.4 4.3-9.7
Unstaged 2.3 1.6-3.4
CI, confidence interval; LRS, likelihood ratio statistic.
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Figure 4 Observed survival according to clinical stage.
decline of cancer of the cervix in developing countries as in
Bangalore. is the increase in age at marriage amidst a chang-
ing socioeconomic environment. A decline in the incidence of
cancer of the cervix has also been reported from Bombay
(Jayant, 1986).
Examination of the decline in cervical cancer according to
clinical stage was of interest. Thus the ASR of stage I and
stage II disease showed no change during the 8 year period.
However, the ASR of both stage III and stage IV disease
declined. Similarly, when the trends in stage proportions for
each calendar year were observed a statistically significant
decline in proportion of stage IV disease was seen. Whether
this is an indication of patients in the area seeking early
diagnosis and treatment because of greater awareness of their
disease and its symptoms remains to be determined.
Nearly 70% of patients presented with stage III disease or
higher at diagnosis. Even in a developing country, such as
here in India, there is a difference of 33% in observed 5 year
survival between patients surviving stage I (5 year survival
63.3%) and stage III (5 year survival 30.3%) disease. Thus.
there should be a corresponding improvement in 5 year
survival if patients with stage III disease were to be diag-
nosed at stage I. This then is the concept of 'downstaging'
for cancer of the cervix. in the context of the developing
world (Stjernsward et al.. 1982). wherein a higher proportion
of patients are diagnosed at an earlier stage of the disease.
thereby giving an opportunity for curative treatments and
consequent improved survival. A combination of professional
and public education with improved diagnostic and
therapeutic facilities would make possible this 'shift' to ear-
lier stage at diagnosis.
The mortality rate presented for all the years combined is
an underestimate of the true picture of mortality due to
cervical cancer in the population. This is mainly because the
method used to collect information on vital status did not
allow details of deaths to be obtained for patients who were
diagnosed as having cervical cancer before commencement of
the registry in 1982, and who died during 1982 or later. Thus.
the average (18.0 100 000) age-standardised mortality rates
for the last three years (1987, 1988. 1989) of this study are a
better reflection of the mortality due to this disease than the
average age-standardised mortality rate (13.3 100 000) of the
entire 8 year period. The mortality incidence ratio calculated
for the average of these last three years is 0.66, which is fairly
high compared with that seen in the western world. Miller et
al. (1992) and Giles et al. (1993) in their data from the US
surveillance epidemiology end results (SEER) and Victorian
Cancer Registry report these ratios as 0.33 and 0.31 respec-
tively.
The inadequate system of registration and certification of
cause of death is a barrier to determining mortality. In
addition, inadequate follow-up of patients makes it very
difficult to obtain information on survival. In the West the
term 'follow-up' refers to the reassessment of disease status
and. if necessary, further treatment by the treating doctor of
patients who have completed initial or subsequent cancer-
directed treatment. However. in India the term 'follow-up' is
also applied to patients who are lost even before investiga-
tions are done or are completed though they have a clinical
diagnosis of cancer. It is also applied to patients in whom a
diagnosis of cancer is established but who fail to turn up for
treatment or are lost during treatment (the category of
patients who do not comply with treatment) and to the
group of patients who complete the initial and&or subsequent
treatment but do not report to the treatment centre for a
'check-up'. Finally, no information is available on patients
who have terminal or advanced cancer and who go home or
are sent home to 'die' (Nandakumar et al., 1990). The
reasons for the above state of affairs are several and include
lack of awareness about disease, economic factors and the
poor quality of patient care, but then this is not the focus of
this discussion. Suffice to say that the above serves to high-
light the need to obtain adequate information on vital status
through active follow-up in order to determine reliable sur-
vival estimates.
The results on survival for a developing country such as
India are not unexpected. The 5 year relative survival of
38.3% is low compared with that seen in Scotland (58.7%)
(Black et al.. 1993) and that in the United States (68% in
whites and 60% in blacks) (Miller et al., 1992). The propor-
tion of patients presenting at a late stage of the disease is one
reason for this comparatively low survival in Bangalore. The
data presented here show that only 3.4% of women present-
ed at localised or stage I disease compared with 48% in the
SEER data of USA. However, when the survival of patients
with stage I or localised disease is considered. 5 year survival
in Bangalore is just 63.3% compared with 89.2% survival in
the United States (Miller et al.. 1992). This suggests that
aspects of treatment management including that of patients
not complying with treatment, as mentioned above, have a
bearing on outcome.
In our study age did not appear to influence relative
survival. nor did the survival change because of educational
status or patient professing a particular religion. The
difference in survival seen between literates and illiterates on
univariate analysis but not after adjustment for stage in
multivariate analysis suggests that education is probably only
a confounder strongly associated with stage of disease. Im-
proved survival was not observed during the 8 year period.
reflecting the absence of primary and secondary prevention
programmes and also the lack of any impact. as yet, on
patient care of the opening of several cancer therapy centres
in the region. However, the lack of any apparent improve-
ment in survival could reflect the relatively short study
period.
A low incidence of cancer of the cervix has been reported
in countries where the population is predominantly Muslim
(Tomatis et al., 1990). and this was also reflected in the
registry data at Bangalore. where the incidence of cervical
cancer among Muslims was less than half that seen in Hindu
females. However, the fact that mortality or survival was not
different amongst the religious groups suggests that one is
probably dealing with the same biological disease.
The incidence, mortality and survival figures on a popula-
tion basis provide baseline data for cancer control program-
mes of this common, important preventable cancer. The
added component of clinical stage of disease would help in
evaluating screening programmes. whether they be screening
through cytology or only clinical examination. In the absence
of any such data elsewhere in the country or region the
figures of various rates and proportions presented in this
paper provide a starting point for designing. implementing
and, to a certain extent, evaluating prevention and treatment
programmes in other parts of the state and country.
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